I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an inconvenient truth?

Rezultati

Naziv:	I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an inconvenient truth?
Autori:	Verburg, Frederik A.; Giovanella, Luca; Iakovou, Ioannis; Konijnenberg, Mark W.; Langsteger, Werner; Lassmann, Michael; Mihailović, Jasna ; Luster, Markus
Godina:	2018
Publikacija:	European Journal of Nuclear Medicine and Molecular Imaging
ISSN:	1619-7070 European Journal of Nuclear Medicine and Molecular Imaging Pretraži identifikator
Tip rezultata:	Naučni članak
Kolacija:	vol. 45 br. 13 str. 2247-2249
DOI:	10.1007/s00259-018-4184-z
WoS-ID:	000450713500001
Scopus-ID:	2-s2.0-85054710502
URI:	https://enauka.gov.rs/handle/123456789/380276
Izvor metapodataka:	Migrirano iz RIS podataka
M-kategorija:	21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+

9
SCOPUS^TM

6
OpenCitations

7
WEB OF SCIENCE^TM

Alt metrika

Dimensions

Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.